1832 Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-661,700
| Closed | -$60.3M | – | 852 |
|
|
2023
Q2 | $60.3M | Buy |
661,700
+530,800
| +406% | +$48.4M | 0.07% | 162 |
|
|
2023
Q1 | $8.63M | Buy |
+130,900
| New | +$8.63M | 0.01% | 365 |
|
|
2022
Q4 | – | Sell |
-88,100
| Closed | -$6.02M | – | 885 |
|
|
2022
Q3 | $6.02M | Buy |
+88,100
| New | +$6.02M | 0.01% | 397 |
|